WO2005039619A1 - Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia - Google Patents
Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia Download PDFInfo
- Publication number
- WO2005039619A1 WO2005039619A1 PCT/US2004/027777 US2004027777W WO2005039619A1 WO 2005039619 A1 WO2005039619 A1 WO 2005039619A1 US 2004027777 W US2004027777 W US 2004027777W WO 2005039619 A1 WO2005039619 A1 WO 2005039619A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- prostaglandin
- dosage form
- factor family
- trefoil factor
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0414868-1A BRPI0414868A (en) | 2003-10-03 | 2004-08-25 | compositions and methods comprising prostaglandin-related compounds and trifoliate factor family peptides for the treatment of glaucoma with reduced hyperemia |
CA002541123A CA2541123A1 (en) | 2003-10-03 | 2004-08-25 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
JP2006533858A JP2007507498A (en) | 2003-10-03 | 2004-08-25 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of less congestive glaucoma |
US10/521,367 US7244768B2 (en) | 2003-10-03 | 2004-08-25 | Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
AU2004283091A AU2004283091A1 (en) | 2003-10-03 | 2004-08-25 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
EP04782288A EP1667705A1 (en) | 2003-10-03 | 2004-08-25 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
US11/761,498 US7332526B2 (en) | 2003-10-03 | 2007-06-12 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
US11/761,486 US20070270346A1 (en) | 2003-10-03 | 2007-06-12 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50844503P | 2003-10-03 | 2003-10-03 | |
US60/508,445 | 2003-10-03 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10521367 A-371-Of-International | 2004-08-25 | ||
US11/761,498 Continuation US7332526B2 (en) | 2003-10-03 | 2007-06-12 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
US11/761,486 Continuation US20070270346A1 (en) | 2003-10-03 | 2007-06-12 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005039619A1 true WO2005039619A1 (en) | 2005-05-06 |
Family
ID=34520000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/027777 WO2005039619A1 (en) | 2003-10-03 | 2004-08-25 | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
Country Status (7)
Country | Link |
---|---|
US (3) | US7244768B2 (en) |
EP (1) | EP1667705A1 (en) |
JP (1) | JP2007507498A (en) |
AU (1) | AU2004283091A1 (en) |
BR (1) | BRPI0414868A (en) |
CA (1) | CA2541123A1 (en) |
WO (1) | WO2005039619A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7538082B2 (en) | 2001-04-24 | 2009-05-26 | The General Hospital Corporation | Methods and compositions for treating oral and esophageal lesions |
USRE41028E1 (en) | 1996-04-12 | 2009-12-01 | The General Hospital Corporation | Treating eye disorders intestinal trefoil proteins |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221840B1 (en) * | 1991-02-14 | 2001-04-24 | The General Hospital Corporation | Intestinal trefoil proteins |
US20030186882A1 (en) * | 2001-07-31 | 2003-10-02 | Podolsky Daniel K. | Methods and compositions for treating and preventing distal bowel lesions |
US20030185838A1 (en) * | 2001-11-28 | 2003-10-02 | Podolsky Daniel K. | Methods and compositions for treating lesions of the respiratory epithelium |
US20040171544A1 (en) * | 2001-04-24 | 2004-09-02 | Barker Nicholas P. | Trefoil domain-containing polypeptides and uses thereof |
US20030105016A1 (en) * | 2001-09-06 | 2003-06-05 | Podolsky Daniel K. | Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
US20060189526A1 (en) * | 2002-04-24 | 2006-08-24 | Podolsky Daniel K | Compositions containing an intestinal trefoil peptide and a mucoadhesive |
US20030181384A1 (en) * | 2001-09-06 | 2003-09-25 | Podolsky Daniel K. | Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
AU2002334886B2 (en) * | 2001-10-05 | 2008-07-31 | The General Hospital Corporation | Methods and compositions for treating dermal lesions |
US20030185839A1 (en) * | 2001-10-05 | 2003-10-02 | Podolsky Daniel K. | Methods and compositions for treating dermal lesions |
US20060188471A1 (en) * | 2002-10-31 | 2006-08-24 | Podolsky Daniel K | Methods of treating epithelial lesions |
CN103393483B (en) * | 2006-03-31 | 2016-08-24 | 玛提治疗有限公司 | Medicine release method, structure and composition for nose tear system |
ITRM20070510A1 (en) * | 2007-10-02 | 2009-04-03 | Rmfa Trading S A | OPHTHALMIC COMPOSITIONS BASED ON TAMARINDO SEED POLYESACCARIDE AND HYALURONIC ACID. |
WO2009073457A1 (en) * | 2007-11-30 | 2009-06-11 | Bausch & Lomb Incorporated | Methods and compositions for the rescue of a filtering bleb |
EP2575971B1 (en) * | 2010-05-24 | 2015-12-16 | Indena S.p.A. | Combined plant extracts for use in the treatment of microbial infections |
US10272040B2 (en) | 2010-08-12 | 2019-04-30 | Nanyang Technological University | Liposomal formulation for ocular drug delivery |
US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
JP7116945B2 (en) * | 2015-07-13 | 2022-08-12 | 株式会社 東北テクノアーチ | Composition for protecting optic nerve |
CN106822007B (en) | 2015-09-11 | 2021-12-31 | 西姆莱斯股份公司 | Oral preparation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0435682A2 (en) * | 1989-12-28 | 1991-07-03 | Allergan, Inc. | The use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension |
US20030186886A1 (en) * | 1996-04-12 | 2003-10-02 | Podolsky Daniel K. | Treating eye disorders using intestinal trefoil proteins |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3740592A (en) * | 1970-11-12 | 1973-06-19 | Energy Res Corp | Thermionic converter |
US4039352A (en) * | 1971-09-13 | 1977-08-02 | Institutul De Cercetaro Energetice Industriale Si Proictari Utilaje Energetice | High efficiency thermoelectric generator for the direct conversion of heat into electrical energy |
US4011582A (en) * | 1973-10-30 | 1977-03-08 | General Electric Company | Deep power diode |
US4063965A (en) * | 1974-10-30 | 1977-12-20 | General Electric Company | Making deep power diodes |
AT382040B (en) * | 1983-03-01 | 1986-12-29 | Guenther Stangl | METHOD FOR PRODUCING OPTICALLY STRUCTURED FILTERS FOR ELECTROMAGNETIC RADIATION AND OPTICALLY STRUCTURED FILTERS |
US5068535A (en) * | 1988-03-07 | 1991-11-26 | University Of Houston - University Park | Time-of-flight ion-scattering spectrometer for scattering and recoiling for electron density and structure |
JPH0812913B2 (en) * | 1988-11-07 | 1996-02-07 | 日本電気株式会社 | Semiconductor device and manufacturing method thereof |
US5023671A (en) * | 1989-03-27 | 1991-06-11 | International Business Machines Corporation | Microstructures which provide superlattice effects and one-dimensional carrier gas channels |
US5233205A (en) * | 1989-09-25 | 1993-08-03 | Hitachi, Ltd. | Quantum wave circuit |
US5247223A (en) * | 1990-06-30 | 1993-09-21 | Sony Corporation | Quantum interference semiconductor device |
DE69132928T2 (en) * | 1990-08-09 | 2002-08-22 | Canon Kk | Arrangements for coupling or decoupling electron waves and arrangements with a quantum interference effect |
DE69124766T2 (en) * | 1990-10-08 | 1997-07-03 | Canon Kk | Electron wave interference device and related method for modulating an interference current |
US5204588A (en) * | 1991-01-14 | 1993-04-20 | Sony Corporation | Quantum phase interference transistor |
JP2744711B2 (en) * | 1991-03-28 | 1998-04-28 | 光技術研究開発株式会社 | Quantum wire structure and manufacturing method thereof |
JP3235144B2 (en) * | 1991-08-02 | 2001-12-04 | ソニー株式会社 | How to make a quantum box train |
JP2730357B2 (en) * | 1991-11-18 | 1998-03-25 | 松下電器産業株式会社 | Electronic component mounted connector and method of manufacturing the same |
FR2684807B1 (en) * | 1991-12-10 | 2004-06-11 | Thomson Csf | QUANTUM WELL TRANSISTOR WITH RESONANT TUNNEL EFFECT. |
US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
JP3455987B2 (en) * | 1993-02-26 | 2003-10-14 | ソニー株式会社 | Quantum box assembly device and information processing method |
US5579232A (en) * | 1993-03-29 | 1996-11-26 | General Electric Company | System and method including neural net for tool break detection |
US5705321A (en) * | 1993-09-30 | 1998-01-06 | The University Of New Mexico | Method for manufacture of quantum sized periodic structures in Si materials |
JP2991931B2 (en) * | 1994-07-12 | 1999-12-20 | 松下電器産業株式会社 | Semiconductor devices and their manufacturing methods |
US5503963A (en) * | 1994-07-29 | 1996-04-02 | The Trustees Of Boston University | Process for manufacturing optical data storage disk stamper |
JPH0870173A (en) * | 1994-08-30 | 1996-03-12 | Matsushita Electric Ind Co Ltd | Circuit board |
US5699668A (en) * | 1995-03-30 | 1997-12-23 | Boreaus Technical Limited | Multiple electrostatic gas phase heat pump and method |
US5772905A (en) * | 1995-11-15 | 1998-06-30 | Regents Of The University Of Minnesota | Nanoimprint lithography |
US5722242A (en) * | 1995-12-15 | 1998-03-03 | Borealis Technical Limited | Method and apparatus for improved vacuum diode heat pump |
US6214651B1 (en) * | 1996-05-20 | 2001-04-10 | Borealis Technical Limited | Doped diamond for vacuum diode heat pumps and vacuum diode thermionic generators |
US5675972A (en) * | 1996-09-25 | 1997-10-14 | Borealis Technical Limited | Method and apparatus for vacuum diode-based devices with electride-coated electrodes |
US7140102B2 (en) * | 2001-09-02 | 2006-11-28 | Borealis Technical Limited | Electrode sandwich separation |
US6225205B1 (en) * | 1998-01-22 | 2001-05-01 | Ricoh Microelectronics Company, Ltd. | Method of forming bump electrodes |
US6281514B1 (en) * | 1998-02-09 | 2001-08-28 | Borealis Technical Limited | Method for increasing of tunneling through a potential barrier |
US6117344A (en) * | 1998-03-20 | 2000-09-12 | Borealis Technical Limited | Method for manufacturing low work function surfaces |
JP2003527841A (en) * | 1999-12-23 | 2003-09-24 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | Trefoil domain containing polynucleotides, polypeptides and antibodies |
US6417060B2 (en) * | 2000-02-25 | 2002-07-09 | Borealis Technical Limited | Method for making a diode device |
WO2002102403A1 (en) | 2001-06-14 | 2002-12-27 | Novo Nordisk A/S | Mucosal repair by tff dimer peptides |
US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
US6984628B2 (en) * | 2003-07-15 | 2006-01-10 | Allergan, Inc. | Ophthalmic compositions comprising trefoil factor family peptides |
-
2004
- 2004-08-25 AU AU2004283091A patent/AU2004283091A1/en not_active Abandoned
- 2004-08-25 EP EP04782288A patent/EP1667705A1/en not_active Withdrawn
- 2004-08-25 BR BRPI0414868-1A patent/BRPI0414868A/en not_active Application Discontinuation
- 2004-08-25 WO PCT/US2004/027777 patent/WO2005039619A1/en not_active Application Discontinuation
- 2004-08-25 JP JP2006533858A patent/JP2007507498A/en active Pending
- 2004-08-25 US US10/521,367 patent/US7244768B2/en not_active Expired - Fee Related
- 2004-08-25 CA CA002541123A patent/CA2541123A1/en not_active Abandoned
-
2007
- 2007-06-12 US US11/761,486 patent/US20070270346A1/en not_active Abandoned
- 2007-06-12 US US11/761,498 patent/US7332526B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0435682A2 (en) * | 1989-12-28 | 1991-07-03 | Allergan, Inc. | The use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension |
US20030186886A1 (en) * | 1996-04-12 | 2003-10-02 | Podolsky Daniel K. | Treating eye disorders using intestinal trefoil proteins |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE41028E1 (en) | 1996-04-12 | 2009-12-01 | The General Hospital Corporation | Treating eye disorders intestinal trefoil proteins |
US7538082B2 (en) | 2001-04-24 | 2009-05-26 | The General Hospital Corporation | Methods and compositions for treating oral and esophageal lesions |
Also Published As
Publication number | Publication date |
---|---|
BRPI0414868A (en) | 2006-11-28 |
JP2007507498A (en) | 2007-03-29 |
US7332526B2 (en) | 2008-02-19 |
AU2004283091A1 (en) | 2005-05-06 |
CA2541123A1 (en) | 2005-05-06 |
US20070270346A1 (en) | 2007-11-22 |
EP1667705A1 (en) | 2006-06-14 |
US20070244051A1 (en) | 2007-10-18 |
US20060046958A1 (en) | 2006-03-02 |
US7244768B2 (en) | 2007-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7332526B2 (en) | Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia | |
EP1442033B1 (en) | Omega-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists | |
US20070112058A1 (en) | Novel prostamides for the treatment of glaucoma and related diseases | |
US9890118B2 (en) | Prostamides for the treatment of glaucoma and related diseases | |
JP2005511607A (en) | Wireless microphone communication system | |
US6984628B2 (en) | Ophthalmic compositions comprising trefoil factor family peptides | |
JP2001522893A (en) | Cyclopentaneheptane (ene) acid, 2-heteroarylalkenyl derivatives as pharmaceuticals | |
US6376533B1 (en) | Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists | |
US6586462B2 (en) | ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists | |
EP1438104B1 (en) | Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists | |
JP2005507413A6 (en) | Ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists | |
KR20020050237A (en) | Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye | |
JPH11228397A (en) | Corneal disease treatment agent for topical application to eye | |
AU2002363319A1 (en) | Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2006046958 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10521367 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004782288 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2541123 Country of ref document: CA Ref document number: 2006533858 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004283091 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2004283091 Country of ref document: AU Date of ref document: 20040825 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004283091 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004782288 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0414868 Country of ref document: BR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2004782288 Country of ref document: EP |